Tianjin Pharmaceutical Da Ren Tang ( SGX:T14) completed the disposal of a 12% stake in Tianjin TSKF Pharmaceutical to Haleon China and Haleon CH SARL, according to a late Friday filing with the Singapore Exchange.
Shares of the company were up over 2% in recent trading.
The disposal was completed after the company received the transfer price of around 1.62 billion yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.